Home > Insider Trading > Filing (0001453687-24-000115)

Filing Details

Accession Number:: 0001453687-24-000115
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-04 17:58:13
Reporting Period:: 2024-10-02

Accepted Time:: 2024-10-04 17:58:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1453687	Cartesian Therapeutics Inc.	RNAC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055624	A Timothy Springer	36 Woodman Road Chestnut Hill MA 02467		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-02	1,801,314	$0.00	7,818,045	No	4	J	Direct
Common Stock	Acquisiton	2024-10-02	5,514	$17.38	7,823,559	No	4	P	Direct
Common Stock	Disposition	2024-10-02	2,119,193	$0.00	529,798	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2024-10-02	317,879	$0.00	330,695	No	4	J	Indirect	By wife
Common Stock	Acquisiton	2024-10-03	29,847	$18.25	7,853,406	No	4	P	Direct
Common Stock	Acquisiton	2024-10-03	10,249	$19.01	7,863,655	No	4	P	Direct
Common Stock	Acquisiton	2024-10-03	50,489	$20.18	7,914,144	No	4	P	Direct
Common Stock	Acquisiton	2024-10-03	21,278	$21.17	7,935,422	No	4	P	Direct
Common Stock	Acquisiton	2024-10-03	8,043	$21.86	7,943,465	No	4	P	Direct
Common Stock	Acquisiton	2024-10-04	9,892	$21.35	7,953,357	No	4	P	Direct
Common Stock	Acquisiton	2024-10-04	48,880	$22.35	8,002,237	No	4	P	Direct
Common Stock	Acquisiton	2024-10-04	16,650	$23.57	8,018,887	No	4	P	Direct
Common Stock	Acquisiton	2024-10-04	4,879	$23.93	8,023,766	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	P	Direct
No	4	J	Indirect	See Footnote
No	4	J	Indirect	By wife
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (Right to Buy)	Disposition	2024-10-02	133,632	$0.00	133,632	$46.50
Common Stock	Warrant (Right to Buy)	Acquisiton	2024-10-02	113,587	$0.00	113,587	$46.50
Common Stock	Warrant (Right to Buy)	Acquisiton	2024-10-02	20,045	$0.00	20,045	$46.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,408	2022-04-11	2027-04-11	No	4	J	Indirect
113,587	2022-04-11	2027-04-11	No	4	J	Direct
20,045	2022-04-11	2027-04-11	No	4	J	Indirect

Footnotes

Pro rata distribution for no consideration from TAS Partners LLC to the reporting person or the reporting person's spouse, as the case may be. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.17 to $17.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.76 to $18.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $18.76 to $19.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $19.77 to $20.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.78 to $21.77. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.80 to $22.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.87 to $21.86. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.87 to $22.8626. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $22.87 to $23.8699. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $23.87 to $24.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.